Access

Correspondence

Nature 451, 16 (3 January 2008) | doi:10.1038/451016c; Published online 2 January 2008

Slow development impedes the uptake of diagnostics

Chul-So Moon1, Eddy C. Agbo1 & David Sidransky2

  1. Cangen Biotechnologies, Inc., 300 E. Lombard Street, Baltimore, Maryland 21202, USA
  2. Department of Otolaryngology, Johns Hopkins University School of Medicine, and Sidney Kimmel Comprehensive Cancer Center, Cancer Research Building II, 5N.03, 1550 Orleans Street, Baltimore, Maryland 21231, USA

Two conclusions in your Business story 'Missing the mark' (Nature 449, 770–771; 2007) about the usefulness of cancer biomarkers should evoke a response from translational researchers and clinicians.First, you say that the overall impact of early bladder-cancer detection on patient survival rates may be relatively small because surgery remains the treatment of choice.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.